Bourkas A E, Menezes J
J Gen Virol. 1979 Aug;44(2):361-71. doi: 10.1099/0022-1317-44-2-361.
The present paper reports on the induction of two cell surface markers on human lymphoid cells following herpes simplex virus (HSV) infection. While both primary and chronic infections of human lymphoid cells led to the induction of receptors for the Fc region of 7S IgG, chronic HSV infection was also characterized by the induction of surface-bound IgM. Surface and intracellular Fc receptors were detected in the human lymphoid cell line, Raji, infected with HSV types 1 and 2. Under optimal conditions with a multiplicity of infection (m.o.i.) of 50 to 100 p.f.u. per cell, this marker was inducible in only about 53% of the infected cells. Kinetic studies revealed the appearance of these receptors at around 5 h following HSV infection and they reached a plateau 16 to 18 h p.i. Interestingly, this Fc receptor expression (i.e. percentage of positive cells) was found to be similar in primary and chronically HSV-infected Raji cells. Both human leukocyte interferon and phosphonoacetic acid (PAA), an inhibitor of herpesvirus DNA polymerase activity, effectively inhibited Fc receptor synthesis during primary HSV-infection and these two agents suppressed its induction in chronically HSV-infected Raji (Raji-HSV) cells. This inhibitory or suppressive effect, particularly of PAA, suggests that this HSV-induced Fc receptor may represent a late virus function in the infected cell. Unlike primary HSV infection, about 80% of the chronically HSV-infected Raji cells were found to express surface-bound IgM. This IgM induction was suppressed by long-term interferon treatment but not with PAA-treatment. Superinfection studies of interferon and PAA-treated Raji-HSV cells indicate that only the former would develop Fc receptors suggesting a protective role of this IgM against superinfection by HSV.
本文报道了单纯疱疹病毒(HSV)感染后人淋巴细胞上两种细胞表面标志物的诱导情况。人淋巴细胞的原发性和慢性感染均导致7S IgG Fc区受体的诱导,而慢性HSV感染的特征还在于表面结合IgM的诱导。在感染了1型和2型HSV的人淋巴细胞系Raji中检测到了表面和细胞内Fc受体。在最佳条件下,感染复数(m.o.i.)为每细胞50至100个噬斑形成单位(p.f.u.)时,仅约53%的感染细胞可诱导出该标志物。动力学研究显示,这些受体在HSV感染后约5小时出现,并在感染后16至18小时达到平台期。有趣的是,原发性和慢性HSV感染的Raji细胞中这种Fc受体表达(即阳性细胞百分比)相似。人白细胞干扰素和膦甲酸钠(PAA,一种疱疹病毒DNA聚合酶活性抑制剂)在原发性HSV感染期间均有效抑制Fc受体合成,且这两种药物在慢性HSV感染的Raji(Raji-HSV)细胞中也抑制其诱导。这种抑制作用,尤其是PAA的抑制作用,表明这种HSV诱导的Fc受体可能代表感染细胞中病毒的晚期功能。与原发性HSV感染不同,约80%的慢性HSV感染的Raji细胞被发现表达表面结合IgM。长期干扰素治疗可抑制这种IgM的诱导,但PAA治疗则无此作用。对干扰素和PAA处理的Raji-HSV细胞进行的再次感染研究表明,只有前者会产生Fc受体,这表明这种IgM对HSV再次感染具有保护作用。